Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1465 S Grand Blvd
Saint Louis, MO 63104Phone+1 314-577-5647Fax+1 314-268-2775
Education & Training
- Sparrow HospitalResidency, Pediatrics, 2010 - 2013
- B. J. Medical College AhmedabadClass of 2005
- Children's Hospital of MichiganFellowship, Pediatric Gastroenterology
Certifications & Licensure
- OH State Medical License 2011 - Present
- MO State Medical License 2015 - 2026
- KS State Medical License 2021 - 2022
- MI State Medical License 2010 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Clinical Trials
- Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit Start of enrollment: 2019 Dec 12
Roles: Contact, Principal Investigator
- Neuromodulation for Children With Cystic Fibrosis Experiencing Chronic Abdominal Pain Start of enrollment: 2023 Mar 29
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Ineffective esophageal motility: Characterization and outcomes across pediatric neurogastroenterology and motility centers in the United States.Trevor A Davis, Benjamin D Rogers, Alejandro Llanos-Chea, Amornluck Krasaelap, Darnna Banks
Journal of Pediatric Gastroenterology and Nutrition. 2024-09-01 - Constipation and DIOS: Diagnosis, differential diagnosis, and management.Pavithra Saikumar, Marisa Sadauskas, Sophia Izhar, Baha Moshiree, Dhiren Patel
Pediatric Pulmonology. 2024-09-01 - 1 citationsRemote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force.Jordana E Hoppe, Jacquelyn Sjoberg, Gina Hong, Katie Poch, Edith T Zemanick
Journal of Cystic Fibrosis. 2024-07-01
Press Mentions
- Renexxion Seeks FDA OK to Test Naronapride for GI Problems in CFJanuary 11th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: